Queensland

  • Funded by Coalition for Epidemic Preparedness Innovations (CEPI)
  • Total publications:1000 publications

Grant number: N/A

Grant search

Key facts

  • Disease

    COVID-19
  • start year

    2020
  • Known Financial Commitments (USD)

    $4,500,000
  • Funder

    Coalition for Epidemic Preparedness Innovations (CEPI)
  • Principal Investigator

    Keith Chappel
  • Research Location

    Australia
  • Lead Research Institution

    University of Queensland
  • Research Priority Alignment

    N/A
  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Phase 1 clinical trial

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Clinical Trial, Phase I

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Full length S-protein Molecular clamp (pre-fusion viral insertion proteins are stabilised using a sequence from HIV. This is applicable to type I and III glycoproteins). Phase I safety and immunogenicity

Publicationslinked via Europe PMC

Matrix degradation enhances stress relaxation, regulating cell adhesion and spreading.

Alcohol industry involvement in the delayed South Africa Draft Liquor Amendment Bill 2016: a case study based on freedom of information requests.

Pupil Wizard: an app to enhance knowledge of pupillary abnormalities.

Streptococcus pneumoniae serotype 33H: a novel serotype with frameshift mutations in the acetyltransferase gene wciG.

An enhanced national-scale urban tree canopy cover dataset for the United States.

Impact of postpartum physical activity on maternal anthropometrics: a systematic review and meta-analysis.

Redox dye-mediated fluorescence energy transfer of carbon nanotube-based nanosensors.

Disease burden by <i>ALPL</i> variant number in patients with non-life-threatening hypophosphatasia in the Global HPP Registry.